Protonix Iv

   
Google
 
Web NewDrugInformation.com

Protonix Iv


Drug - Protonix Iv
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; IV (INFUSION)
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Pantoprazole Sodium
Multiple ingredients are in alphabetical order.

Strength - EQ 40MG BASE/VIAL
The potency of the active ingredient(s), Pantoprazole Sodium. May repeat for multiple part products.

Applicant - WYETH PHARMS INC
The firm name holding legal responsibility for Protonix Iv. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020988
The FDA assigned number to Protonix Iv. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Protonix Iv. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 22, 2001
The date Protonix Iv was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Protonix Iv. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Protonix Iv is in. Format is RX, OTC, DISCN.

Applicant Full Name - Wyeth Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Protonix Iv.

Protonix Iv